Drug Topics
JANUARY 24, 2025
Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University, provides best tips and practices for providing maternity care.
STAT
JANUARY 18, 2025
A recent Nature Medicine research report is sounding an alarm. The risk of developing dementia by the age of 95 is 42%. The finding that the risk of dementia increases with age is well described. What’s new and startling about this result is the number. It’s double prior estimates. The investigator team, led by researchers at New York University and funded by the National Institutes of Health, reported even higher risk estimates for women, people who self-report Black racial identi
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JANUARY 21, 2025
Accessia Health helps ease the burden of managing a rare disease or chronic condition.
The Checkup by Singlecare
JANUARY 22, 2025
Propranolol is widely prescribed to treat heart conditions such as high blood pressure, arrhythmias, angina (chest pain), or a combination of these conditions. It belongs to a class of drugs known as beta-adrenergic receptor antagonists, more commonly called beta blockers. Understanding this medications duration of action can help you better manage symptoms and avoid potential side effects from missed doses.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JANUARY 20, 2025
The lawsuit alleges Walgreens has been filling prescriptions in violation of the Controlled Substances Act since 2012.
STAT
JANUARY 24, 2025
Pfizer agreed to pay nearly $60 million to resolve allegations that its Biohaven Pharmaceuticals unit paid kickbacks to entice physicians to prescribe a migraine treatment. The alleged violations occurred before Pfizer bought the company three years ago, according to the U.S. Department of Justice. The authorities alleged that, from March 2020 through September 2022, Biohaven improperly paid doctors speaking fees and for meals at “high end” restaurants in order to persuade them to
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Checkup by Singlecare
JANUARY 20, 2025
Losing weight can be tough. And it can be even tougher for people who have Type 2 diabetes, which can impair weight loss. Thats why it might seem natural to treat both obesity and diabetes simultaneously. For the past half-century, phentermine has been one of the most commonly prescribed weight loss drugs, and metformin has been one of the most popular diabetes medicationsand its also prescribed off-label for weight reduction.
Drug Topics
JANUARY 22, 2025
The US government is entrusting mRNA vaccine pioneers Moderna to develop protection for the gradually increasing threat of avian influenza.
Pharmacy Times
JANUARY 21, 2025
Esketamine targets glutamate, the most abundant neurotransmitters in the brain.
PharmaVoice
JANUARY 24, 2025
Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the belief the answer could come down to delivery.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 24, 2025
The federal government is officially backing down from a courtroom fight with the country’s largest Medicare Advantage insurer, just three days after it said it was ready to spar.
Drug Topics
JANUARY 24, 2025
Jonathan Watanabe, PharmD, MS, PhD, BCGP, joined Drug Topics to discuss how pharmacists can facilitate improved patient outcomes through collaborative care.
Pharmacy Times
JANUARY 22, 2025
The FDA approved treosulfan, in combination with fludarabine, for patients 1 year of age and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
PharmaVoice
JANUARY 22, 2025
The company is kicking off the year with a new Novartis partnership and renewed focus on metabolic aging targets.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JANUARY 24, 2025
Change Healthcare now estimates that 190 million people were impacted in the massive cyberattack that took down its services nearly a year ago. | Change Healthcare now estimates that 190 million people were impacted in the massive cyberattack that took down its services nearly a year ago.
Drug Topics
JANUARY 23, 2025
Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the -opioid receptor.
Pharmaceutical Technology
JANUARY 21, 2025
Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.
Hospital Pharmacy Europe
JANUARY 23, 2025
In a study comparing the performance of multiple trigger tools in identifying medication-related hospital readmissions, the OPERAM tool performed the best, identifying the highest number of both the total medication-related (re)admissions (MRRs) and potential preventable MRRs. Trigger tools are used to identify and measure adverse events over time and recognise MRRs.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JANUARY 23, 2025
Prime Therapeutics, a PBM owned by Blue Cross plans, violated federal and state antitrust laws through a collaboration with Express Scripts and must pay AIDS Healthcare Foundation more than $10 million, an arbitrator ruled.
Drug Topics
JANUARY 24, 2025
Along with discount drug card company GoodRx, the suit is aimed at CVS Caremark, Express Scripts, MedImpact Healthcare Systems, and Navitus Health Solutions.
Pharmacy Times
JANUARY 21, 2025
Investigators found that the polypill treatment improved cardiovascular disease and lowered health care costs.
PhRMA
JANUARY 24, 2025
It has been widely acknowledged that long patent examination delays cripple innovation, hinder economies, impede job creation and frustrate the launch of new products. Increased patent review times cost the global economy $10 billion annually, and are particularly harmful for small start-up firms. Every year of delay reduces the start-up’s employment growth by 21% and sales growth by 28% over the five years following the approval of the patent application.
Fierce Healthcare
JANUARY 22, 2025
In 2022, negotiated commercial prices for evaluation and management office visits were 11% higher for hospital-affiliated PCPs and 8% higher for private equity-affiliated PCPs, as compared to those at independent practices.
Drug Topics
JANUARY 23, 2025
A discussion with Natalie DiPietro Mager, PharmD, PhD, professor of pharmacy practice at Ohio Northern University.
PharmaVoice
JANUARY 21, 2025
Early planning and market research are crucial in an era of rising cost pressures.
Pharmacy Times
JANUARY 22, 2025
An infusion and specialty clinical pharmacist is a valuable integrated member of the health care team as demonstrated by cost avoidance and high satisfaction reported by both veterans and specialty providers.
Fierce Healthcare
JANUARY 23, 2025
While the year's 57 Chapter 11 filings didn't reach the highs of 2023, physician practice bankruptcies continue to trend up while hospitals saw their largest bankruptcy "by far in the last 30 years.
Drug Topics
JANUARY 21, 2025
Kurt Proctor, BS Pharm, PhD, CCHS, President of the NCPA Innovation Center, discussed his organizations efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.
PharmaVoice
JANUARY 21, 2025
Novel drug approvals have set the stage for more breakthroughs in pharma.
Pharmacy Times
JANUARY 22, 2025
Vusolimogene oderparepvec in combination with nivolumab is being assessed to treat individuals with unresectable or metastatic stage IIIb-IV cutaneous melanoma.
Fierce Healthcare
JANUARY 22, 2025
The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage star ratings. | The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage star ratings.
Drug Topics
JANUARY 24, 2025
Heather Folz, PharmD, BCACP and Christina H. Sherrill, PharmD, BCACP, BC-ADM discuss challenges pharmacists may face when implementing CGM services and how they can help raise awareness.
Med Ed 101
JANUARY 22, 2025
Do you ever get those questions where you know you are correct but you have to check the literature? I believe I’ve come across this order once or twice in my career: oral lorazepam PRN for a seizure. Can this be done? Here are the details on why this shouldn’t be done. Can I give […] The post Oral Lorazepam PRN For A Seizure? Is This Right?
Expert insights. Personalized for you.
247 
Let's personalize your content